AI Genome Analysis Raises Concerns Over Standards and Clinical Interpretation
Artificial intelligence (AI) is rapidly advancing the accessibility and speed of genome analysis, with systems like Claude now capable of interpreting entire genomes in minutes for a minimal cost. This marks a significant shift from the past, where such analyses required extensive human expertise and time. For example, a task that once took a team of 30 people nearly a year to complete can now be attempted by AI in about 30 minutes for approximately $5. While AI can re-identify important genetic findings, including disease risks and medication responses, its interpretations are influenced by factors such as the reference genome used and the sequencing technology. Many existing genomes were produced using 'short-read sequencing,' which can be unreliable in complex or repetitive DNA regions where disease-causing variants might occur. Furthermore, current reference genomes often do not adequately represent the full diversity of human genomes, potentially making variant detection difficult in under-represented...
